| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 7.02e-05 | 3 | 91 | 2 | 1.10.3730.10 | |
| Domain | P5CR_dimer | 7.02e-05 | 3 | 91 | 2 | PF14748 | |
| Domain | P5CR_dimer | 7.02e-05 | 3 | 91 | 2 | IPR029036 | |
| Domain | P5CR | 1.40e-04 | 4 | 91 | 2 | PS00521 | |
| Domain | Pyrroline-COOH_reductase | 1.40e-04 | 4 | 91 | 2 | IPR000304 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.28e-04 | 177 | 91 | 6 | IPR003591 | |
| Domain | LRR_TYP | 2.28e-04 | 177 | 91 | 6 | SM00369 | |
| Domain | BRIX | 2.33e-04 | 5 | 91 | 2 | PS50833 | |
| Domain | Brix | 2.33e-04 | 5 | 91 | 2 | SM00879 | |
| Domain | Brix | 2.33e-04 | 5 | 91 | 2 | IPR007109 | |
| Domain | Brix | 2.33e-04 | 5 | 91 | 2 | PF04427 | |
| Domain | Leu-rich_rpt | 3.59e-04 | 271 | 91 | 7 | IPR001611 | |
| Domain | ProC_N | 4.85e-04 | 7 | 91 | 2 | IPR028939 | |
| Domain | F420_oxidored | 4.85e-04 | 7 | 91 | 2 | PF03807 | |
| Domain | - | 9.78e-04 | 321 | 91 | 7 | 3.80.10.10 | |
| Domain | Cys-rich_flank_reg_C | 9.79e-04 | 90 | 91 | 4 | IPR000483 | |
| Domain | LRRCT | 9.79e-04 | 90 | 91 | 4 | SM00082 | |
| Domain | L_dom-like | 1.11e-03 | 328 | 91 | 7 | IPR032675 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | IPR000372 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | SM00013 | |
| Domain | Ig_I-set | 2.37e-03 | 190 | 91 | 5 | IPR013098 | |
| Domain | I-set | 2.37e-03 | 190 | 91 | 5 | PF07679 | |
| Domain | 6-PGluconate_DH_C-like | 3.80e-03 | 19 | 91 | 2 | IPR008927 | |
| Domain | LRR_1 | 4.35e-03 | 219 | 91 | 5 | PF00560 | |
| Domain | UDPGT | 4.64e-03 | 21 | 91 | 2 | PF00201 | |
| Domain | UDPGT | 4.64e-03 | 21 | 91 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 4.64e-03 | 21 | 91 | 2 | IPR002213 | |
| Domain | IGc2 | 5.85e-03 | 235 | 91 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.85e-03 | 235 | 91 | 5 | IPR003598 | |
| Domain | - | 5.94e-03 | 148 | 91 | 4 | 2.60.40.150 | |
| Pubmed | CILP2 LRFN4 PXDN AMOT ANKRD28 FASTKD5 TTC17 ITGA2B NRROS HSD17B11 CTSA | 8.58e-07 | 613 | 94 | 11 | 22268729 | |
| Pubmed | 2.18e-06 | 34 | 94 | 4 | 18848646 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15471764 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25352669 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20351249 | ||
| Pubmed | Recruitment of histone deacetylase 4 to the N-terminal region of estrogen receptor alpha. | 7.23e-06 | 2 | 94 | 2 | 16051668 | |
| Pubmed | Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH. | 7.23e-06 | 2 | 94 | 2 | 2722838 | |
| Pubmed | Roles of Estrogen Receptor-α and the Coactivator MED1 During Human Endometrial Decidualization. | 7.23e-06 | 2 | 94 | 2 | 26849466 | |
| Pubmed | SLC12A6 TRPM4 IARS2 PPAN ATP7B AHNAK USP32 PYCR1 TTC17 STAM SLC39A10 HSD17B11 | 1.01e-05 | 952 | 94 | 12 | 38569033 | |
| Pubmed | 1.28e-05 | 285 | 94 | 7 | 34369648 | ||
| Pubmed | IGSF10 PPP2R5A AMOT NOA1 DISC1 ANKRD28 STAM KDM6A SHC3 VPS13B | 1.70e-05 | 686 | 94 | 10 | 29987050 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.90e-05 | 202 | 94 | 6 | 33005030 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 17693257 | ||
| Pubmed | Cloning and localization of a conventional kinesin motor expressed exclusively in neurons. | 2.16e-05 | 3 | 94 | 2 | 7514426 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 29187405 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 21768290 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30068641 | ||
| Pubmed | Functional specialization in proline biosynthesis of melanoma. | 2.16e-05 | 3 | 94 | 2 | 23024808 | |
| Pubmed | Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. | 2.16e-05 | 3 | 94 | 2 | 18593928 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18593923 | ||
| Pubmed | Selected SALM (synaptic adhesion-like molecule) family proteins regulate synapse formation. | 2.16e-05 | 3 | 94 | 2 | 20410109 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 33342936 | ||
| Pubmed | PHKA1 PPP2R5A CEP72 AHNAK SYNE2 PYCR1 ANKRD28 RICTOR STAM SLC39A10 KDM6A NOTCH1 | 2.62e-05 | 1049 | 94 | 12 | 27880917 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 21841772 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 10760302 | ||
| Pubmed | Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors. | 4.32e-05 | 4 | 94 | 2 | 18593893 | |
| Pubmed | The SALM/Lrfn family of leucine-rich repeat-containing cell adhesion molecules. | 4.32e-05 | 4 | 94 | 2 | 21736948 | |
| Pubmed | Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. | 4.32e-05 | 4 | 94 | 2 | 11986669 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 10770935 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 10964943 | ||
| Pubmed | 5.34e-05 | 27 | 94 | 3 | 20347265 | ||
| Pubmed | 6.89e-05 | 504 | 94 | 8 | 34432599 | ||
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 17502350 | ||
| Pubmed | UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome. | 7.19e-05 | 5 | 94 | 2 | 29073101 | |
| Pubmed | KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. | 7.19e-05 | 5 | 94 | 2 | 7528108 | |
| Pubmed | The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha. | 7.19e-05 | 5 | 94 | 2 | 15886699 | |
| Pubmed | Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. | 7.19e-05 | 5 | 94 | 2 | 15256501 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 19893013 | ||
| Pubmed | 8.00e-05 | 515 | 94 | 8 | 31617661 | ||
| Pubmed | 8.14e-05 | 31 | 94 | 3 | 32546759 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 19489872 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 19838210 | ||
| Pubmed | Chromosomal localization reveals three kinesin heavy chain genes in mouse. | 1.08e-04 | 6 | 94 | 2 | 9782088 | |
| Pubmed | Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling. | 1.08e-04 | 6 | 94 | 2 | 26437242 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | EPHX1 IARS2 NOA1 AHNAK PYCR1 FASTKD5 SLC39A10 HSD17B11 CTSA ALG1L2 PYCR3 CREB5 PCYOX1 | 1.43e-04 | 1451 | 94 | 13 | 30550785 |
| Pubmed | Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. | 1.50e-04 | 7 | 94 | 2 | 15312650 | |
| Pubmed | mNUDC is required for plus-end-directed transport of cytoplasmic dynein and dynactins by kinesin-1. | 1.50e-04 | 7 | 94 | 2 | 20019668 | |
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 19162321 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 16828986 | ||
| Pubmed | Stable kinesin and dynein assemblies drive the axonal transport of mammalian prion protein vesicles. | 1.50e-04 | 7 | 94 | 2 | 21335237 | |
| Pubmed | PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex. | 1.50e-04 | 7 | 94 | 2 | 16554032 | |
| Pubmed | Analysis of Kif5b expression during mouse kidney development. | 1.50e-04 | 7 | 94 | 2 | 25885434 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.71e-04 | 430 | 94 | 7 | 35044719 | |
| Pubmed | IARS2 ITSN1 SYNE2 PYCR1 ANKRD28 FASTKD5 RICTOR TTC17 SLC39A10 ASCC3 PYCR3 VPS13B DMXL1 | 1.82e-04 | 1487 | 94 | 13 | 33957083 | |
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 24413532 | ||
| Pubmed | 2.13e-04 | 446 | 94 | 7 | 24255178 | ||
| Pubmed | 2.16e-04 | 108 | 94 | 4 | 19956635 | ||
| Pubmed | 2.18e-04 | 43 | 94 | 3 | 18510611 | ||
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 12535528 | ||
| Pubmed | Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins. | 2.57e-04 | 9 | 94 | 2 | 9624122 | |
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 24684754 | ||
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 12738788 | ||
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 21976701 | ||
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 9653119 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 3.21e-04 | 10 | 94 | 2 | 25303530 | |
| Pubmed | Notch and retinoic acid signals regulate macrophage formation from endocardium downstream of Nkx2-5. | 3.21e-04 | 10 | 94 | 2 | 37669937 | |
| Pubmed | 3.21e-04 | 10 | 94 | 2 | 16798735 | ||
| Pubmed | 3.37e-04 | 481 | 94 | 7 | 28190767 | ||
| Pubmed | 3.73e-04 | 225 | 94 | 5 | 12168954 | ||
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 18285546 | ||
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 26204127 | ||
| Pubmed | 4.29e-04 | 54 | 94 | 3 | 36237976 | ||
| Pubmed | 4.69e-04 | 12 | 94 | 2 | 18391015 | ||
| Pubmed | Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis. | 4.69e-04 | 12 | 94 | 2 | 14960280 | |
| Pubmed | The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. | 4.69e-04 | 12 | 94 | 2 | 15834408 | |
| Pubmed | 4.69e-04 | 12 | 94 | 2 | 16018997 | ||
| Pubmed | 4.69e-04 | 12 | 94 | 2 | 16301330 | ||
| Pubmed | 5.53e-04 | 13 | 94 | 2 | 22693459 | ||
| Pubmed | 5.53e-04 | 13 | 94 | 2 | 11266503 | ||
| Pubmed | 5.79e-04 | 140 | 94 | 4 | 20819778 | ||
| Pubmed | 5.95e-04 | 141 | 94 | 4 | 18636124 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 6.44e-04 | 14 | 94 | 2 | 17641689 | |
| Pubmed | PLK2 ITSN1 ZNF197 USP32 NFKBID TTC17 KIF5A KIF5C STAM IDS KDM6A | 7.01e-04 | 1285 | 94 | 11 | 35914814 | |
| Pubmed | 7.40e-04 | 65 | 94 | 3 | 23453885 | ||
| Pubmed | 7.42e-04 | 15 | 94 | 2 | 20526338 | ||
| Pubmed | 7.42e-04 | 15 | 94 | 2 | 15654505 | ||
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 7.73e-04 | 66 | 94 | 3 | 20679960 | |
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 19693267 | ||
| Pubmed | Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. | 8.46e-04 | 16 | 94 | 2 | 19415745 | |
| Pubmed | 9.57e-04 | 17 | 94 | 2 | 20808911 | ||
| Pubmed | 9.57e-04 | 17 | 94 | 2 | 19690890 | ||
| Pubmed | Deafness in mice lacking the T-box transcription factor Tbx18 in otic fibrocytes. | 9.57e-04 | 17 | 94 | 2 | 18353863 | |
| Pubmed | 9.99e-04 | 162 | 94 | 4 | 25826454 | ||
| Pubmed | 1.08e-03 | 74 | 94 | 3 | 17255364 | ||
| Pubmed | 1.12e-03 | 1153 | 94 | 10 | 29845934 | ||
| Pubmed | 1.17e-03 | 76 | 94 | 3 | 22323595 | ||
| Pubmed | 1.17e-03 | 169 | 94 | 4 | 31462741 | ||
| Pubmed | 1.20e-03 | 19 | 94 | 2 | 29885287 | ||
| Pubmed | 1.20e-03 | 19 | 94 | 2 | 19656773 | ||
| Pubmed | 1.20e-03 | 19 | 94 | 2 | 17392787 | ||
| Interaction | FBXO2 interactions | 1.65e-05 | 411 | 91 | 10 | int:FBXO2 | |
| Interaction | FBXO6 interactions | CILP2 LRFN4 PXDN AMOT ANKRD28 FASTKD5 TTC17 ITGA2B NRROS NUDT9 HSD17B11 CTSA PCYOX1 | 1.95e-05 | 717 | 91 | 13 | int:FBXO6 |
| Interaction | BAG2 interactions | VWA5B2 SLC12A6 HDAC4 AMOT DISC1 AHNAK RICTOR STAM ASCC3 KDM6A VPS13B NLRP5 | 2.29e-05 | 622 | 91 | 12 | int:BAG2 |
| Cytoband | 1q42.1 | 2.70e-04 | 12 | 94 | 2 | 1q42.1 | |
| Cytoband | 4q22.1 | 1.31e-03 | 26 | 94 | 2 | 4q22.1 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 3.89e-06 | 437 | 94 | 10 | M1610 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 5.24e-06 | 122 | 94 | 6 | M10276 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | 5.54e-06 | 455 | 94 | 10 | MM1189 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 1.39e-05 | 85 | 94 | 5 | MM720 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 1.39e-05 | 85 | 94 | 5 | M1723 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 3.03e-05 | 166 | 94 | 6 | M17163 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 3.13e-05 | 167 | 94 | 6 | MM1057 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 3.34e-05 | 250 | 94 | 7 | M39170 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 7.85e-05 | 197 | 94 | 6 | M9862 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 8.30e-05 | 199 | 94 | 6 | M9759 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 8.54e-05 | 200 | 94 | 6 | M8497 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-06 | 172 | 94 | 6 | 3b9be685fcd1634498a603b692f5ac6ddd0de176 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 2.95e-06 | 188 | 94 | 6 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.33e-06 | 192 | 94 | 6 | 37d0d0fdd6bc3114d546020b472b6df9392392f4 | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|World / Lineage and Cell class | 3.53e-06 | 194 | 94 | 6 | cd12d01f6f2f12bbc33ed523bc678d3965074974 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-9|TCGA-Kidney / Sample_Type by Project: Shred V9 | 8.97e-06 | 132 | 94 | 5 | f1ef63a4842ab6ca584a9dcc2dd5b2108fc990aa | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 64 | 94 | 4 | c13a7edad4d52a955e2c2247139246522d9e4463 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 64 | 94 | 4 | eefb4573ec4ff8efe602543ccbe555dbef1c4d54 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 64 | 94 | 4 | fcc0f3fa0b462620d031aae810a01fadb7c01202 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_Erythro-Mega|lymph-node_spleen / Manually curated celltypes from each tissue | 3.12e-05 | 171 | 94 | 5 | 3ecd0a074344179c57eb2d9a857ba594904d00fa | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Eosinophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.30e-05 | 173 | 94 | 5 | a85cead231e03945fabbc7762540ad21fe4299df | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.10e-05 | 181 | 94 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega-Mega-Mast|blood / Manually curated celltypes from each tissue | 4.20e-05 | 182 | 94 | 5 | 1923b5669901f828e890416c22d1f1d21a4a2c6a | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.43e-05 | 184 | 94 | 5 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-05 | 187 | 94 | 5 | e1d6c1194476cf26969e405b0951796fed519f44 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.91e-05 | 188 | 94 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 190 | 94 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.29e-05 | 191 | 94 | 5 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 191 | 94 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 5.42e-05 | 192 | 94 | 5 | cbc304c704e8524eee24a1619d0fbb2cf96c4976 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.42e-05 | 192 | 94 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.56e-05 | 193 | 94 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-05 | 194 | 94 | 5 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 5.83e-05 | 195 | 94 | 5 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | CV-Mild-0|Mild / Virus stimulation, Condition and Cluster | 5.83e-05 | 195 | 94 | 5 | 2ffb9a9b6143bb404fe454cd939b573252bba6e9 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.27e-05 | 198 | 94 | 5 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | (1)_T_cell-(12)_Th1|(1)_T_cell / shred on Cell_type and subtype | 6.42e-05 | 199 | 94 | 5 | 15133e0a4ea6cfcc27c1d438d9e854879ea84c30 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.58e-05 | 200 | 94 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.71e-05 | 110 | 94 | 4 | b9c8014fd2820e5ea28a7e02fd24227b99e71eb3 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.71e-05 | 110 | 94 | 4 | ee45592e936d32881c0f3429c21360670e5b3ce3 | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.39e-05 | 194 | 92 | 7 | 2844_UP | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 7351_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.59e-05 | 198 | 92 | 7 | 2536_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.64e-05 | 199 | 92 | 7 | 5994_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | 1.64e-05 | 199 | 92 | 7 | 2956_UP | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 199 | 92 | 7 | 1472_DN | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 1.64e-05 | 199 | 92 | 7 | 7290_UP | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 2.27e-06 | 9 | 90 | 3 | DOID:12377 (implicated_via_orthology) | |
| Disease | level of ADP-ribose pyrophosphatase, mitochondrial in blood serum | 9.20e-06 | 2 | 90 | 2 | OBA_2042674 | |
| Disease | hepatitis (implicated_via_orthology) | 2.75e-05 | 3 | 90 | 2 | DOID:2237 (implicated_via_orthology) | |
| Disease | S-1-pyrroline-5-carboxylate measurement | 5.50e-05 | 4 | 90 | 2 | EFO_0800136 | |
| Disease | ADP-ribose pyrophosphatase, mitochondrial measurement | 5.50e-05 | 4 | 90 | 2 | EFO_0801349 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.51e-05 | 28 | 90 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 1.12e-04 | 616 | 90 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.12e-04 | 616 | 90 | 9 | C0376358 | |
| Disease | SPARC-like protein 1 measurement | 1.37e-04 | 6 | 90 | 2 | EFO_0008289 | |
| Disease | Lung Neoplasms | 1.64e-04 | 265 | 90 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.68e-04 | 266 | 90 | 6 | C0242379 | |
| Disease | hair color | 3.87e-04 | 311 | 90 | 6 | EFO_0003924 | |
| Disease | Intellectual Disability | 4.43e-04 | 447 | 90 | 7 | C3714756 | |
| Disease | fetal genotype effect measurement, body weights and measures | 4.57e-04 | 49 | 90 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | X-18913 measurement | 4.97e-04 | 11 | 90 | 2 | EFO_0800795 | |
| Disease | hair colour measurement | 5.89e-04 | 615 | 90 | 8 | EFO_0007822 | |
| Disease | motor neuron disease (implicated_via_orthology) | 5.95e-04 | 12 | 90 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 5.95e-04 | 12 | 90 | 2 | DOID:3319 (is_marker_for) | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 6.42e-04 | 55 | 90 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | hypothyroidism (implicated_via_orthology) | 7.02e-04 | 13 | 90 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 8.81e-04 | 139 | 90 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 8.81e-04 | 139 | 90 | 4 | C0025363 | |
| Disease | Mental deficiency | 8.81e-04 | 139 | 90 | 4 | C0917816 | |
| Disease | Bladder Neoplasm | 9.04e-04 | 140 | 90 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 9.29e-04 | 141 | 90 | 4 | C0005684 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 9.41e-04 | 15 | 90 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 9.41e-04 | 15 | 90 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 9.41e-04 | 15 | 90 | 2 | C0154091 | |
| Disease | amyotrophic lateral sclerosis | 1.03e-03 | 145 | 90 | 4 | MONDO_0004976 | |
| Disease | anthranilic acid measurement | 1.07e-03 | 16 | 90 | 2 | EFO_0010460 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.21e-03 | 17 | 90 | 2 | OBA_2045173 | |
| Disease | unipolar depression, bipolar disorder | 1.35e-03 | 156 | 90 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Carcinoma of bladder | 1.36e-03 | 18 | 90 | 2 | C0699885 | |
| Disease | Colorectal Carcinoma | 1.38e-03 | 702 | 90 | 8 | C0009402 | |
| Disease | Carcinomatosis | 1.59e-03 | 163 | 90 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.59e-03 | 163 | 90 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.59e-03 | 163 | 90 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.59e-03 | 163 | 90 | 4 | C0205696 | |
| Disease | Carcinoma | 1.62e-03 | 164 | 90 | 4 | C0007097 | |
| Disease | Lymphoma, Diffuse | 1.86e-03 | 21 | 90 | 2 | C3714542 | |
| Disease | Low Grade Lymphoma (neoplasm) | 1.86e-03 | 21 | 90 | 2 | C0079747 | |
| Disease | Lymphoma, Intermediate-Grade | 1.86e-03 | 21 | 90 | 2 | C0079741 | |
| Disease | High Grade Lymphoma (neoplasm) | 1.86e-03 | 21 | 90 | 2 | C0079740 | |
| Disease | Diffuse Mixed-Cell Lymphoma | 1.86e-03 | 21 | 90 | 2 | C0079757 | |
| Disease | Lymphoma, Undifferentiated | 1.86e-03 | 21 | 90 | 2 | C0024306 | |
| Disease | Reticulosarcoma | 1.86e-03 | 21 | 90 | 2 | C0024302 | |
| Disease | Lymphoma, Mixed-Cell | 1.86e-03 | 21 | 90 | 2 | C0024304 | |
| Disease | progranulin measurement | 2.04e-03 | 22 | 90 | 2 | EFO_0004625 | |
| Disease | Lymphoma, Non-Hodgkin, Familial | 2.04e-03 | 22 | 90 | 2 | C4721532 | |
| Disease | Lymphoma, Small Noncleaved-Cell | 2.04e-03 | 22 | 90 | 2 | C0079770 | |
| Disease | QRS duration | 2.22e-03 | 298 | 90 | 5 | EFO_0005055 | |
| Disease | phosphatidylserines measurement | 2.23e-03 | 23 | 90 | 2 | EFO_0020049 | |
| Disease | alcohol dependence | 2.42e-03 | 183 | 90 | 4 | MONDO_0007079 | |
| Disease | Cerebral Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0750936 | |
| Disease | Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 2.64e-03 | 25 | 90 | 2 | C0547065 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 2.64e-03 | 25 | 90 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Pilocytic Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 2.64e-03 | 25 | 90 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 2.85e-03 | 26 | 90 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 2.85e-03 | 26 | 90 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 2.85e-03 | 26 | 90 | 2 | C0334582 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGPLPNQHSLKGMEH | 221 | Q4VCS5 | |
| LQHRLFMKLGSTHSP | 26 | C9J202 | |
| AQAHGHMKPLTASQV | 1386 | P35670 | |
| KLALSAASGLAHLHM | 306 | P36896 | |
| AHLHMEIVGTQGKPG | 316 | P36896 | |
| GKTPLHMTALHGRFS | 306 | O15084 | |
| TQLLNTMGHHTVGLK | 71 | Q09666 | |
| EKITHLGHSLMSLTG | 41 | Q9P209 | |
| LPAMTKNNHGHIVTV | 156 | Q8NBQ5 | |
| TANITAGHLLMHLIG | 161 | P00846 | |
| AGHLLMHLIGSATLA | 166 | P00846 | |
| LAVGLSHGDHSSMKL | 271 | Q6ZW61 | |
| PALLEAKMHAISGNH | 586 | Q9NRI5 | |
| GHLLHSSLPGLSRME | 1491 | Q9Y485 | |
| LGTMSEAKPHLITHG | 176 | Q96G21 | |
| LVKHMKNIHLPDGSA | 1346 | O75747 | |
| LGAAKMLLHSEQHPG | 211 | P32322 | |
| NMIDNIPKGTFSHLH | 181 | Q96NI6 | |
| VMQTLKHLNSHLPNG | 396 | P28039 | |
| LKAALTHHPAAMSNG | 236 | Q02930 | |
| DMLHQLLSLHGGSTP | 611 | P51787 | |
| SLQHGMVGPLHSSLA | 2341 | P46531 | |
| GGAAHSPLLQHMVLL | 406 | P56524 | |
| KAHGNTALHMAAALP | 241 | Q8NI38 | |
| TLKHPAHHGMGKNLA | 86 | Q14695 | |
| AHHGMGKNLATSLPT | 91 | Q14695 | |
| PSAMKNLLHHILSGK | 951 | P46020 | |
| HLGHNTMVTKPCGAL | 4716 | Q2LD37 | |
| GKLVLPGGIDTHTHM | 56 | Q14117 | |
| GNLLSHVGHTILGMN | 1116 | O15550 | |
| EAGGSVIHPLNLHMK | 86 | Q9UHG3 | |
| HTKASGMALLHQIQG | 6 | P03372 | |
| DSSGNKIMHPVSGKH | 181 | Q9BW91 | |
| GNHSKALEMTGIHAP | 1356 | O15018 | |
| IKNLFSPIMSENHGH | 721 | Q14005 | |
| EHMGLSVGIKQPIGH | 226 | P11150 | |
| SHPGHSNDLMLIKLN | 146 | Q9Y337 | |
| MLGTHPHLRQLDLGS | 776 | P59047 | |
| LFIGTLSCHPHGVKM | 661 | Q6R327 | |
| HIAFLTIKGAGHMVP | 446 | P10619 | |
| GPLAMTVHLLANSGH | 6 | Q9H5Z6 | |
| KAFVILGIPHSHSML | 211 | Q7L8L6 | |
| LMLHSNGIHTIPDKT | 86 | Q6WRI0 | |
| SHVKGLHLNMALVLS | 241 | P07099 | |
| IPSVMKAHGAHLKAS | 651 | Q9P2D3 | |
| MQGQGALKESHIHLP | 1 | Q96N68 | |
| QALDLHHPKLMPGSG | 206 | P14138 | |
| SHDKTMSGHLTGPQA | 231 | Q15811 | |
| GKTHTMEGKLHDPQL | 91 | Q12840 | |
| MSVGKVFHPGISSNH | 131 | P22304 | |
| ANDGHLATLLPMLHT | 401 | Q6UWV6 | |
| HQLTQGRLGHKPMVS | 71 | Q9Y6Q1 | |
| HLIQSCGLGGMKHNT | 841 | Q9UHW9 | |
| MSGDALLHLLPHSQG | 451 | Q9ULF5 | |
| SVHHGAPLQLLKSMG | 366 | Q9Y2B1 | |
| HAGHTLLQIPMGGKE | 581 | Q8NC60 | |
| LSNLHKMGAPEAGLA | 116 | P0C7X4 | |
| LMEHHSGSQGPLLTT | 946 | Q15648 | |
| GFLRKMPSLSHLNLH | 346 | Q86YC3 | |
| LHGKGSQDPSMKVHI | 211 | P59540 | |
| LHVLGDGHLSGMLPS | 386 | Q96PX1 | |
| LLQGHMRSHTGEKPF | 226 | Q9NQ03 | |
| GSDLPLHKMAIQGFH | 1236 | Q8WXH0 | |
| GKTHTMEGKLHDPQL | 91 | O60282 | |
| SRMESHGLPNKVHLS | 516 | O75343 | |
| FVLTGMHNGQAKHLL | 531 | Q92529 | |
| QPLMGHKDHTHLSPG | 866 | Q14940 | |
| HVTMAKGTGLVHTAP | 381 | Q9NSE4 | |
| LDLGGKHSPICHTTM | 566 | P08514 | |
| HIPAFTMGIKHSLHL | 251 | Q8IXM7 | |
| TAKMLLHEGQHPAQL | 216 | Q53H96 | |
| GASSHLLSPAGQHLM | 266 | Q8IXZ3 | |
| LIPMHTAKGLALFHA | 276 | Q15172 | |
| GFPKMAKHSHGLALQ | 231 | Q08AH1 | |
| SNLKLTLAFGIGMHH | 1606 | Q8N3C0 | |
| AASQIHMPGHVEALK | 666 | Q8IUL8 | |
| HNVTMLHQSGKFLIP | 51 | Q6NUS8 | |
| SSLLMHLRNHSGEKP | 411 | O14709 | |
| HPHTKGSQILMDLSH | 66 | O76050 | |
| LVLNSFGPHGMHVKL | 141 | Q9NQ55 | |
| THLVPGTFNHLESMK | 171 | Q92626 | |
| GGVAGHDLNSLKHMP | 56 | Q8IZ13 | |
| NLLGHMHLHAGSKPF | 561 | Q8N1W2 | |
| GFLNKHAMTVHPTDL | 761 | Q8IZM8 | |
| MIAHITGLKPGDFIH | 236 | P04818 | |
| HKDPHVAMQALTLLG | 56 | Q92783 | |
| GNLPTSMHTLDHLHG | 951 | Q96AE7 | |
| ITTLNHLHMLAGGVD | 146 | Q5VIR6 | |
| GGLFSLHANMKGIVH | 36 | Q8TE23 | |
| HQPHLMLEGGSLSSA | 276 | Q8N398 | |
| KLSEGLMDGSPHFLH | 1476 | Q7Z7G8 | |
| GHSTHLSGGKQVLPM | 3556 | Q7Z7G8 | |
| QVAHTIHMSALGLPG | 61 | Q969M1 | |
| LGHPKTKAFITHGGM | 361 | Q6UWM9 | |
| GSLKVHMRLHTGAKP | 1236 | Q9UL36 | |
| LKEHMQTHQAGPSLS | 1701 | Q9UL36 | |
| NGAHMSLLPDKKTVH | 531 | Q9NYY3 | |
| LSGLNVHIAMKHPTK | 1426 | Q9C0G0 | |
| AKHGVHLQGPVSMGL | 1111 | Q9Y6X0 | |
| SHGLSLGHFLTPMRL | 446 | Q8TD43 | |
| GILNAHDTTKMGHLT | 321 | Q8NFA0 | |
| THLNGGHNSLTMSPK | 11 | Q9C0D4 | |
| GAMPALHTLNLDHNL | 166 | Q6PJG9 |